NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spyre and certain of its officers and/or directors […]
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Oklo Inc. ("Oklo" or the "Company") (NYSE:OKLO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Oklo and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, INC. ("Franklin" or the "Company") (NYSE:BEN).��Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com�or 646-581-9980, ext.�7980. The investigation concerns whether Franklin and certain of its officers and/or directors have engaged in
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Icon Public Limited Company ("ICON" or the "Company") (NASDAQ:ICLR).��Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com�or 646-581-9980, ext.�7980. The investigation concerns whether ICON and certain of its officers and/or directors have engaged
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ:NGNE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neurogene and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") (NASDAQ:ARVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Arvinas and certain of its officers and/or directors have
(NASDAQ:VVPR), Delivery of 25 Tusker vehicles includes next gen model with upgraded cruise control, safety and multimedia features from February 2025 All 25 vehicles have been allocated due to strong demand from customers and partners Tembo is working with fleet owners to assist them in securing the NSW government fleet incentive of up to A$15,000
NEWTOWN, Pa., Jan. 22, 2025 (GLOBE NEWSWIRE) — Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by Allegheny Health Network (“AHN”). On January 17, 2025, AHN began notifying affected patients that a data breach at IntraSystems LLC, a computer consulting firm, compromised person information. To join this
Leading Construction Firms Named to Project as The Raleigh Launches Tower Construction Ahead of 2027 Completion; SHVO Enlists Newmark to Lead Recapitalization SHVO, the ultra-luxury real estate development and investment firm, has named its construction partners at The Raleigh, A Rosewood Hotel & Residences in Miami Beach. Americaribe Moriarty Joint Venture (AMJV), a partnership between
(NYSE:EIX), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Edison International (NYSE: EIX) resulting from allegations that Edison may have issued materially misleading business information to the investing public. SO WHAT: If you purchased